id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-N-0134-0009,FDA,FDA-1999-N-0134,HHS/USDA Action Plan,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:16:59Z,,0,0,09000064804aebb5
FDA-1999-N-0134-0007,FDA,FDA-1999-N-0134,Listeriosis in the United States,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:00Z,,0,0,09000064804aebb3
FDA-1999-N-0134-0006,FDA,FDA-1999-N-0134,"Agenda for March 19, 2001 Public Meeting",Other,LST-List,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:00Z,,0,0,09000064804aebb2
FDA-1999-N-0134-0008,FDA,FDA-1999-N-0134,Draft Assessment of the Relative Risk,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:16:58Z,,0,0,09000064804aebb4
FDA-1999-N-0134-0005,FDA,FDA-1999-N-0134,FDA,Notice,NEC-Notice of Extension,2001-05-22T04:00:00Z,2001,5,2001-05-22T04:00:00Z,2001-07-19T03:59:59Z,2008-04-25T00:16:59Z,,0,0,09000064804aeb9a
FDA-1999-N-0134-0004,FDA,FDA-1999-N-0134,FDA,Notice,NM-Notice of Meeting,2001-03-07T05:00:00Z,2001,3,2001-03-07T05:00:00Z,2001-03-20T04:59:59Z,2008-04-25T00:16:54Z,,0,0,09000064804aeb93
FDA-1999-N-0134-0003,FDA,FDA-1999-N-0134,FDA,Notice,NAD-Notice of Availability of Data,2001-01-22T05:00:00Z,2001,1,2001-01-22T05:00:00Z,2001-03-21T04:59:59Z,2008-04-25T00:16:59Z,,0,0,09000064804aeb8f